Experience

• • A European manufacturing group in an internal investigation into allegations of improper payments through third parties in China.
  • A European manufacturing group in an internal investigation into allegations of Code of Conduct violations in China.
  • A multinational pharmaceutical company in an internal investigation relating to bribery and corruption allegations in China.
  • A global medical device company in an internal investigation relating to bribery and corruption allegations involving employees in China.
  • A European manufacturing company in compliance due diligence and follow-up anti-corruption investigations in its multiple business partners in mainland China.
  • A leading U.S. consumer company in conducting risk assessments of business partners throughout Asia.
  • A leading U.S.-headquartered financial services company in an internal investigation of its Chinese joint venture.
  • A leading U.S. financial services company in compliance due diligence of a proposed acquisition in China.
  • A U.S.-based chemical company in due diligence on a potential acquisition in Asia.
  • A leading U.S. investment firm in compliance due diligence of a unicorn technology company in China.
  • A European manufacturing company in an internal investigation of allegations relating to alleged improper payments in China.